Search
Taking a deep dive into atopic dermatitis with the CEO of Apogee Therapeutics
Michael Henderson describes the rationale behind Apogee's IL13 program and how it has been designed to have a longer half-life.
Dec 7, 2023
top of page
Search
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.
bottom of page